You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Hungary Patent: E044978


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E044978

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 28, 2026 Viiv Hlthcare APRETUDE cabotegravir
⤷  Get Started Free Apr 28, 2026 Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine
⤷  Get Started Free Apr 28, 2026 Viiv Hlthcare VOCABRIA cabotegravir sodium
⤷  Get Started Free Feb 4, 2031 Viiv Hlthcare APRETUDE cabotegravir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Drug Patent HUE044978

Last updated: August 2, 2025


Introduction

The Hungarian patent HUE044978 pertains to a novel pharmaceutical invention registered under the Hungarian Intellectual Property Office. Analyzing its scope and claims involves evaluating the patent's detailed description, claim set, legal scope, and the broader patent landscape for similar therapeutics within Hungary and the European Union (EU). This assessment aims to inform stakeholders—including pharmaceutical companies, generic manufacturers, and legal professionals—about the patent’s exclusivity parameters, potential challenges, and the competitive environment.


Patent Overview and Basic Details

Patent Identification: HUE044978
Filing Date: [Exact date unspecified—assumed prior to the publication date]
Patent Status: Active or expired (pending confirmation)
Protection Area: Hungary (European patent application possibly covering the EU)
Field of Invention: Likely pertains to a pharmaceutical compound, formulation, or medical use (details depend on patent disclosures)


Scope and Claims of HUE044978

1. Claim Structure and Claim Types

Hungarian patents typically contain multiple claims delineating the invention's scope. These are classified as:

  • Independent Claims: Define the core invention with broad scope.
  • Dependent Claims: Narrower claims that specify particular embodiments or embodiments of the independent claims.

Without access to the original document, the general structure likely includes:

  • A composition claim covering a specific drug compound or a combination thereof.
  • A method of use claim describing therapeutic application.
  • Formulation or process claims related to manufacturing or formulation specifics.

2. Core Patent Claims (Hypothetical Example)

Suppose the patent pertains to a novel pharmaceutical compound for treating a chronic disease such as osteoporosis or certain cancers. The core claim would likely read:

"A pharmaceutical composition comprising [Active Ingredient], characterized by [specific structural feature or activity], and its use in the treatment of [disease]."

Alternatively, if it relates to a process, it could specify:

"A method of synthesizing [compound] involving [specific reaction steps], resulting in high yield and purity."

3. Claim breadth and limitations

  • The claims' breadth determines the patent's enforceability and its potential to block competitors.
  • Narrow claims might cover specific chemical variants or formulations.
  • Broad claims might encompass all derivatives with similar structure or activity, which could face validity challenges under patent law.

4. Claim Clarity and Innovation

The claims should articulate the inventive step over known prior art. If the patent claims are narrowly tailored, they might be at risk of invalidation if prior art discloses similar compounds or methods.


Patent Landscape and Related Patents in Hungary and EU

1. Patent Family and International filings

  • The patent HUE044978 may belong to a broader family filed via the Patent Cooperation Treaty (PCT) or the European Patent Convention (EPC), providing protection across multiple jurisdictions.
  • Confirming corresponding European Patent Application or national patents in neighboring countries is crucial for comprehensive landscape mapping.

2. Competitor Patents and Similar Technologies

  • The landscape includes patents on similar chemical entities, therapeutic uses, or unique formulations.
  • Existing patents from major pharmaceutical companies may overlap, potentially creating freedom-to-operate (FTO) challenges.
  • Patent databases such as EPO Espacenet, WIPO PATENTSCOPE, and the Hungarian Patent Office records should be examined.

3. Patent Validity and Challenges

  • Validity depends on novelty, inventive step, and industrial applicability.
  • Patent oppositions or invalidation proceedings can be initiated if prior art challenges the patent’s validity.

4. Patent Expiry and Patent Life Cycle

  • Typically, patents filed around 20 years before expiry (from filing date).
  • Determining the filing date and grant date informs the remaining patent term.

Legal and Commercial Implications

1. Exclusivity and Market Impact

  • A valid patent grants exclusive rights, preventing generic equivalents.
  • The scope of claims directly affects market exclusivity—broad claims hinder generic entry.

2. Infringement Risks

  • Companies developing similar compounds or formulations must analyze the claims to avoid infringement.
  • The scope also guides patent enforcement strategies and licensing negotiations.

3. Potential for Patent Challenges

  • Competitors may leverage prior art or argue claim invalidity.
  • Patent offices or courts in Hungary and the EU assess these claims during patent prosecution and enforcement.

Conclusion & Summary of Analysis

The Hungarian patent HUE044978 appears to encompass a specific pharmaceutical compound or therapeutic method, with claims designed to cover key aspects of the invention’s composition or use. Its scope hinges on the breadth of the claims and their novelty over existing prior art. The patent landscape surrounding this patent involves similar applications in Hungary and broader EU jurisdictions, with potential overlaps in chemical structure or therapeutic indication.

Effective patent protection hinges on the robustness of the claims and the patent's alignment with existing patents. Commercial strategists should assess potential infringement risks, opportunities for licensing, and the lifecycle of this patent to optimize market positioning.


Key Takeaways

  • Claim scope is critical: Broad claims yield stronger market protection but face higher validity challenges.
  • Landscape vigilance is essential: Identify competing patents in Hungary and EU to evaluate FTO and enforcement opportunities.
  • Patent validity depends on prior art: Ongoing monitoring of prior disclosures can preempt invalidation risks.
  • Strategic patent management: Leveraging auxiliary patents or supplementary applications can extend exclusivity.
  • Legal expertise is paramount: Engage with patent attorneys to interpret claims precisely and execute enforcement or defense strategies.

FAQs

  1. What types of claims are typically included in pharmaceutical patents like HUE044978?
    Pharmaceutical patents generally include composition claims, method of use claims, and process or formulation claims, each defining different aspects of the invention’s scope and protection.

  2. How does the patent landscape affect the commercialization of drugs covered by HUE044978?
    The patent landscape influences market exclusivity, competitive entry, and licensing strategies. Overlapping patents could restrict generic manufacturing unless challenged or circumvented.

  3. What factors determine the enforceability of claims in Hungarian patents?
    Enforceability hinges on the claims' novelty, inventive step, clarity, and absence of prior art. Validity is also assessed through legal proceedings or opposition.

  4. Can the scope of patent HUE044978 be expanded after filing?
    Usually, claims can be amended during prosecution or through secondary filings like continuation applications. Post-grant amendments are limited but possible under certain legal frameworks.

  5. How does the patent landscape in Hungary compare to the broader European patent system?
    Hungary’s patent system adheres to EU and EPC standards, allowing for national, EU, and international patent filings. Strategic filings in multiple jurisdictions enhance protection but require careful management.


References

  1. European Patent Office. (2022). Patent Search and Analysis Tools.
  2. Hungarian Intellectual Property Office. (2022). Patent Laws and Regulations.
  3. WIPO. (2022). Global Patent Landscape Reports.
  4. EPO Espacenet. (2022). Patent Database.
  5. Patent family data and prior art references (if applicable, based on further search).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.